Viridian Therapeutics, Inc. (FRA:1S1)
25.66
-0.04 (-0.16%)
Last updated: Jan 9, 2026, 8:02 AM CET
Viridian Therapeutics Employees
Viridian Therapeutics had 143 employees as of December 31, 2024. The number of employees increased by 49 or 52.13% compared to the previous year.
Employees
143
Change (1Y)
49
Growth (1Y)
52.13%
Revenue / Employee
€421,912
Profits / Employee
€1,462,130
Market Cap
2.61B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 143 | 49 | 52.13% |
| Dec 31, 2023 | 94 | 8 | 9.30% |
| Dec 31, 2022 | 86 | 36 | 72.00% |
| Dec 31, 2021 | 50 | 23 | 85.19% |
| Dec 31, 2020 | 27 | -19 | -41.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Viridian Therapeutics News
- 5 days ago - Viridian Therapeutics Prepares for Transformational 2026 - Benzinga
- 5 days ago - Viridian Therapeutics Prepares for Transformational 2026 - Business Wire
- 9 days ago - Insider Sell: Jennifer Tousignant Sells 2,272 Shares of Viridian Therapeutics Inc (VRDN) - GuruFocus
- 19 days ago - FDA Accepts Viridian's Veligrotug BLA For Priority Review In Thyroid Eye Disease - Nasdaq
- 20 days ago - Viridian Therapeutics (VRDN) Gains FDA Priority Review for Thyroid Eye Disease Treatment - GuruFocus
- 20 days ago - Viridian Therapeutics Announces BLA Acceptance and Priority Review for Veligrotug for the Treatment of Thyroid Eye Disease - Wallstreet:Online
- 20 days ago - Viridian Therapeutics Announces BLA Acceptance and Priority Review for Veligrotug for the Treatment of Thyroid Eye Disease - Business Wire
- 27 days ago - Viridian Therapeutics (VRDN) Sees 5% Stock Increase - GuruFocus